Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
Novartis
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
Groupe Francophone des Myelodysplasies
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Novartis
Novartis
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Rigshospitalet, Denmark
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Centre Leon Berard
Baylor College of Medicine
European LeukemiaNet
Children's Oncology Group
Obafemi Awolowo University
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Baylor College of Medicine
Baylor College of Medicine
Sir Mortimer B. Davis - Jewish General Hospital
Orca Biosystems, Inc.
Otsuka Beijing Research Institute
University of Jena
University of Jena
Shenzhen TargetRx Co., Ltd.
Fundacion CRIS de Investigación para Vencer el Cáncer
Sun Pharma Advanced Research Company Limited
Columbia University
Imperial College Healthcare NHS Trust
Poitiers University Hospital